Subklavyen ve renal arter stenozu saptanan bir olguda düşük protein C ve protein S aktivitesi
Trombofili cogunlugu venoz sistemde olan tromboza egilim olarak tanimlanma! tadir. Dogal antikoagulanlar olan protein C ve S'nin kahtsal veya edinsel eksiklikle trombofilinin onemli nedenletindendir. Son yillarda aterosklerozlu vakalarda yapil; calismalar trombofili He ateroskleroz patogenezi arastndaki iliskiyi desteklemekted: Bu yazida subklavyen ve renal arter stenozu saptanan bir olguda diisuk protein C i protein S aktivitesi bildirilmis ve trombofili ile ateroskleroz arastndaki iliski tartis: mistir.
A case subclavian and renal arteries stenosis with low activities of protein C and protein S
Thrombophilia is defined as tendency to thrombosis commonly at the venoi system. Inherited and acquired deficiencies of natural anticoagulants, protein C ar. protein S are important causes of thrombophilia. Recent studies including patien with atherosclerosis have shown the relationship between thrombophilia and atheri sclerosis. In this paper, we report low activity of protein C and S in a patient wil renal and subclavien arteries stenosis and we mention about the relationship betwee thrombophilia and atherosclerosis.
___
- 1. Atkins KA, Zehnder JL. Mesenteric artery thrombosis: A case report of combined protein S and protein C deficiency Am J Hematol 1998; 58:246-247.
- 2. Kiechl S, Muipp A, Santer P et al. Poor responce to activated protein C as a prominent risk predictor of advanced atherosclerosis and arterial disease Circulation 1999; 99:614-619.
- 3. Maas R, Boger RH. Old and new cardiovascular risk factors: from unresolved issues to new opportunities. Atheroscler Suppl 2003;4:5-17.
- 4. Meade, TW, Mellows S, Brozovic M et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet, 1986; 2:533-537.
- 5. Meade, TW, Ruddock V, Stirling Y et al. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet, 1993; 342:1076-1079.
- 6. Folsom, AR, Wu KK, Rosamond WD et al. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation, 1997; 96: 1102-1108.
- 7. Heinrich, J, Balleisen L, Schulte H et al. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb, 1994; 14:54-59.
- 8. Scarabin, PY, Aillaud MF, Amouyel P et al. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Thromb Haemost, 1998; 80:749-756.
- 9. Tracy, RP, Bovill EG, Yanez D et al. Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Results from The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol, 1995; 15:1269-1279.
- 10.Levy PJ, Gonzalez MF, Hornung CA et al. A prospective evaluation of atherosclerotic risk factors and hypercoagulability in young adults with premature lower extremity atherosclerosis J Vasc Surg 1996; 23:36-43.
- 11.Wiesel ML, Borg JY, Grunebaum L et al. Influence of protein S deficiency on the arterial thrombosis risk Presse Med 1991; 8;20:1023-1027.
- 12.Cho YP, Lee DH, Jang HJ et al. Peripheral arterial insufficiency associated with protein C deficiency Br J Radiol 2002; 75:843-846.
- 13.Lentz SR, Fernandez JA, Griffin JH et al. Impaired Anticoagulant Response to Infusion of Thrombin in Atherosclerotic Monkeys Associated With Acquired Defects in the Protein C System Arterioscler Thromb Vasc Biol 1999; 19:1744-1750.
- 14.Vig S, Chitolie A, Sleight S et al. Prevalence and risk of thrombophilia defects in vascular patients. Eur J Vasc Endovasc Surg 2004; 28:124-131.